Novozymes A/S | 392.60 |
Date/Time | 06/23 / 16:18 |
Chg. / Chg.(%) | - / |
Bid | - |
Ask | - |
Open | 399.40 |
Previous Close | 402.80 |
High | 403.75 |
Low | 390.55 |
Volume [DKK] | 2,476,921.60 |
Volume [Units] | 6,248 |
Price fixings | 120 |
ISIN | DK0060336014 |
Security | NZYMB/C |
Exchange | Cboe Europe CXE |
Type | Stock |
Other Exchanges
Exchange | Last | Volume | |
---|---|---|---|
Lang & Schwa.. | 56.10 | ![]() |
|
OMX Nordic | 418.10 | ![]() |
339,067 |
Cboe Europe .. | 418.10 | ![]() |
233,054 |
London Inter.. | 417.10 | ![]() |
137,763 |
Turquoise | 417.20 | ![]() |
32,654 |
Nasdaq Other.. | 57.1300 | ![]() |
1,462 |
TradeGate | 56.000 | ![]() |
1,243 |
Cboe Europe .. | 414.20 | ![]() |
447 |
gettex | 55.980 | ![]() |
10 |
Frankfurt | 54.0400 | ![]() |
0 |
München | 53.72 | ![]() |
0 |
Düsseldorf | 55.86 | ![]() |
0 |
Berlin | 56.28 | ![]() |
0 |
Stuttgart | 56.020 | ![]() |
0 |
Vienna Globa.. | 56.14 | ![]() |
0 |
Quotrix | 54.0600 | ![]() |
|
Cboe Europe .. | 392.60 | 6,248 | |
Xetra | 54.84 | 21 | |
Mexico | 1,158.77 | ![]() |
762 |
News
- NMD Pharma Raises €35 Million in a new Financing
02/15/2022 / 13:00 - GlobeNewswire - NMD Pharma Raises €35 Million in a new Financing
02/15/2022 / 07:00 - GlobeNewswire - Novozymes delivers strong 2021 full-year results and expects continued, solid progress in 2022
02/01/2022 / 08:01 - GlobeNewswire - CENTOGENE Announces CEO to Take Temporary Medical Leave of Absence – Biopharmaceutical Industry Veteran Kim Stratton Appointed as Interim CEO
12/20/2021 / 14:30 - GlobeNewswire - Marrone Bio Optimizes Bioherbicide with New Bacteria Strains, Accelerates Product Development to Enter $27 Billion Herbicide Market¹
12/16/2021 / 14:00 - GlobeNewswire